Drug recall · February 16, 2022
Polymyxin B for Injection USP recall
Why: Presence of Particulate Matter; product complaint of hair discovered in a vial within the lot
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Polymyxin B for Injection USP, 500,000 Units per Vial, 10 mL vials, packaged in 10 vials per carton, Sterile, Rx Only, Distributed by: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-234-10
- Lots / codes
Lot CPB200013, exp 9/2022
- Quantity
- 35,520 vials
- Company
- AuroMedics Pharma LLC, East Windsor, NJ
- Distribution
- Nationwide in the US
- Initiated
- January 26, 2022 · Voluntary: Firm initiated
- Classified
- February 10, 2022
- Reported
- February 16, 2022
- Ended
- August 20, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Polymyxin B
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.